speaker-pic

Neil Bayman

Executive Medical Director
The Christie NHS FT

Neil is Executive Medical Director at The Christie NHS FT since November 2021, having been interim Medical Director since April 2021, and the Trust’s Associate Medical Director (Quality) since June 2017. He holds strategic positions both regionally and nationally and has a proven track record on influencing cancer policy.  

Neil joined The Christie in 2009 as a Consultant Clinical Oncologist with an interest in lung cancer, and he retains a clinical practice. He has extensive system leadership experience and was the inaugural Greater Manchester Cancer Alliance Clinical Director for Lung Cancer from January 2014 to June 2017. In this role he was responsible for delivering transformation of lung cancer pathways and multidisciplinary working, improving access and reducing waiting times for patients across the region. Neil led the introduction of stereotactic radiotherapy for oligometastatic disease at The Christie.

Neil has led practice changing research in lung cancer and mesothelioma, and has held a number of national positions including Specialist Advisor for Oncology for the Care Quality Commission, membership of NHS England’s Chemotherapy Clinical Reference Group and Lung Cancer Clinical Expert Group, and membership of the Royal College of Radiologists’ Clinical Oncology Faculty Board and Professional Support and Standards Board.